Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Page 1
PRL-2 increases Epo and IL-3 responses in hematopoietic cells.
Blood Cells Mol Dis. 2010 Apr 15;44(4):209-14. doi: 10.1016/j.bcmd.2010.02.013. Epub 2010 Mar 11.
Blood Cells Mol Dis. 2010.
PMID: 20226699
Free PMC article.
Tyrosine phosphatase inhibitor-3 sensitizes melanoma and colon cancer to biotherapeutics and chemotherapeutics.
Kundu S, Fan K, Cao M, Lindner DJ, Tuthill R, Liu L, Gerson S, Borden E, Yi T.
Kundu S, et al.
Mol Cancer Ther. 2010 Aug;9(8):2287-96. doi: 10.1158/1535-7163.MCT-10-0159. Epub 2010 Aug 3.
Mol Cancer Ther. 2010.
PMID: 20682647
Free PMC article.
Item in Clipboard
Novel SHP-1 inhibitors tyrosine phosphatase inhibitor-1 and analogs with preclinical anti-tumor activities as tolerated oral agents.
Kundu S, Fan K, Cao M, Lindner DJ, Zhao ZJ, Borden E, Yi T.
Kundu S, et al.
J Immunol. 2010 Jun 1;184(11):6529-36. doi: 10.4049/jimmunol.0903562. Epub 2010 Apr 26.
J Immunol. 2010.
PMID: 20421638
Free PMC article.
Item in Clipboard
Cite
Cite